The San Diego, California based Cytori Therapeutics Inc’s (NASDAQ:CYTX) shares moved up over 11% on Friday after the company announced that it got US endorsement for a latest version of its Puregraft system, used for cosmetic surgery.
Plastic Surgeons use the tool in fat grafting processes that receive fat from one part of the body and insert it into any other part. The gadget takes out unwanted fluid, blood cells and debris from the fat and gets ready it for grafting. [article_latestnews_1]
Shares of medical device manufacturer Cytori moved up 33 cents or 11.5% to settle at $3.16 in afternoon trading.
Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) last session volume of 3.08 million shares was surprisingly lower than its average volume of 651,993.00 shares. The stock after opening at $3.15 hit high price of $3.45 and then closed at $3.13 by scoring +10.60%.
CYTX generated revenue of 10.00 million in the following twelve months and earned -$32.45 million. The Company showed a positive -324.64% in the net profit margin and as well as in its operating margin which remained -294.24%. Company’s annual sales growth for the past five year was 4.75%.
The CYTX past twelve months price to sales ratio was 18.13 and price to cash ratio remained 4.91. As far as the returns are concern, the CYTX return on equity was recorded as -197.76% and -67.02% return on investment while its return on asset stayed at -55.06%.
The stock showed weekly upbeat performance of +19.47% which was maintained for the month at -8.48%. Likewise the positive performance for the quarter was recorded as +42.92% and for the year was -52.65% while the YTD performance remained at +42.27%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. galaxystocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://galaxystocks.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold galaxystocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here